RxDoctor Payments Data

Steven Kissel

Foot & Ankle Surgery · San Antonio, TXNPI 1801052451

Payments from drug & device makers

$3,604in general payments, 2019–2025

Across 129 payments — averaging $27.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$841
  • Treace Medical Concepts, Inc.$725
  • Amgen$305
  • Smith+Nephew$261
  • Aroa Biosurgery Incorporated$139
  • Paratek Pharmaceuticals, Inc.$138
  • plus $1K from 27 others
$68,542in research payments, 2019–2025

Across 11 payments — averaging $6231.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Integra Lifesciences Corporation$43K
  • TEI Medical Inc.$25K

What the payments were for

  • Food & beverage$3,590100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,604 in reported general payments places this provider in the 45th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$870,390
Medicare patients
376
Services billed
2,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone125$900
Doxycycline Hyclate18$575
Cephalexin43$414
Ciclopirox12$303
Levofloxacin17$202
Clindamycin Hcl14$196
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$168
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$147
Ciprofloxacin Hcl13$137
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$117
Tramadol Hcl12$37

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →